Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmology News
Novel treatment shows promise for corneal neovascularization
The avascular nature of the cornea is necessary for optical clarity and optimal vision.
Mastering the balancing act with presbyopia-correcting IOLs
With cataract surgery, our primary goal is simple: to improve visual quality by eliminating the symptoms of poor contrast, blurred vision and glare from the cataract.
Log in or Sign up for Free to view tailored content for your specialty!
Man presents with right-sided headaches, ocular pain and vesicular rash
A 64-year-old man presented to the emergency department at Lahey Hospital with a 6-day history of right-sided headaches, right ocular pain and vesicular rash.
VIDEO: Ellipsoid zone an important biomarker in geographic atrophy
In this video, Barbara Blodi, MD, discusses the importance of the ellipsoid zone as a biomarker in patients with geographic atrophy.
Understand stock and bond index funds for slow, steady growth
One important investment vehicle to understand when working toward slow and steady growth is the index fund.
VIDEO: Makeup line designed to reduce eye irritation
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Diane M. Hilal-Campo, MD, discusses Twenty/Twenty Beauty, the first ophthalmologist-formulated eye makeup line.
VIDEO: Ophthalmologists invited to share research at WIO 2025 Summer Symposium
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer A. Galvin, MD, and Kimberly Winges, MD, encourage all ophthalmologists to submit their research for next year’s meeting.
VIDEO: Omni system with cataract surgery shows long-term IOP reduction
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Noureen Khan, MD, of Northern Virginia Ophthalmology Associates discusses 36-month results from the GEMINI study.
First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia
Ocuphire Pharma has dosed the first participants in the VEGA-3 phase 3 clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia, according to a press release.
Ophthalmology community mourns loss of Stefano Gandolfi, MD
Stefano Gandolfi, MD, a glaucoma specialist and Healio | OSN Europe Edition Board Member, died on Sept. 2 at the age of 64 years.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read